BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
36 results:

  • 1. The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms.
    Kaseb H; Visconte V; Socha DS; Crane GM; Durkin L; Cook JR; Maciejewski JP; Hsi ED; Rogers HJ
    Genes Chromosomes Cancer; 2023 Oct; 62(10):573-580. PubMed ID: 36959701
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML.
    Tsai CH; Tang JL; Tien FM; Kuo YY; Wu DC; Lin CC; Tseng MH; Peng YL; Hou MF; Chuang YK; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
    Blood Adv; 2021 May; 5(10):2456-2466. PubMed ID: 33999144
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Badar T; Szabo A; Litzow M; Burkart M; Yurkiewicz I; Dinner S; Hefazi M; Shallis RM; Podoltsev N; Patel AA; Curran E; Wadleigh M; Balasubramanian S; Yang J; Arslan S; Aldoss I; Mattison R; Cenin D; Siebenaller C; Advani A; Liedtke M; Atallah E
    Bone Marrow Transplant; 2021 Aug; 56(8):1998-2004. PubMed ID: 33824440
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiflora and Gram-Negative Microorganisms Predominate in Infections Affecting Pelvic Endoprostheses Following Tumor Resection.
    Sanders PTJ; Bus MPA; Scheper H; van der Wal RJP; van de Sande MAJ; Bramer JAM; Schaap GR; de Boer MGJ; Dijkstra PDS
    J Bone Joint Surg Am; 2019 May; 101(9):797-803. PubMed ID: 31045667
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
    Chung H; Hong KT; Lee JW; Rhee SJ; Kim S; Yoon SH; Yu KS; Kang HJ
    Bone Marrow Transplant; 2019 Feb; 54(2):284-292. PubMed ID: 29915216
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate cancer.
    Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
    Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
    Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Kentsis A; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
    J Hematol Oncol; 2015 Oct; 8():115. PubMed ID: 26487643
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate cancer Pretreated With Docetaxel Chemotherapy: A Prostate cancer clinical Trial Consortium Study.
    Vaishampayan U; Shevrin D; Stein M; Heilbrun L; Land S; Stark K; Li J; Dickow B; Heath E; Smith D; Fontana J
    Urology; 2015 Dec; 86(6):1206-11. PubMed ID: 26375845
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
    Schwartz GK; Tap WD; Qin LX; Livingston MB; Undevia SD; Chmielowski B; Agulnik M; Schuetze SM; Reed DR; Okuno SH; Ludwig JA; Keedy V; Rietschel P; Kraft AS; Adkins D; Van Tine BA; Brockstein B; Yim V; Bitas C; Abdullah A; Antonescu CR; Condy M; Dickson MA; Vasudeva SD; Ho AL; Doyle LA; Chen HX; Maki RG
    Lancet Oncol; 2013 Apr; 14(4):371-82. PubMed ID: 23477833
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure.
    Demetri GD; Garrett CR; Schöffski P; Shah MH; Verweij J; Leyvraz S; Hurwitz HI; Pousa AL; Le Cesne A; Goldstein D; Paz-Ares L; Blay JY; McArthur GA; Xu QC; Huang X; Harmon CS; Tassell V; Cohen DP; Casali PG
    Clin Cancer Res; 2012 Jun; 18(11):3170-9. PubMed ID: 22661587
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma.
    Iwata H; Tatewaki K; Inoue M; Yokota N; Sato K; Shibamoto Y
    Radiother Oncol; 2012 Sep; 104(3):355-60. PubMed ID: 22398314
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary malignant giant-cell tumor of bone has high survival rate.
    Domovitov SV; Healey JH
    Ann Surg Oncol; 2010 Mar; 17(3):694-701. PubMed ID: 19902306
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.
    Egler RA; Burlingame SM; Nuchtern JG; Russell HV
    Clin Cancer Res; 2008 Nov; 14(21):7028-34. PubMed ID: 18980999
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL
    Br J Haematol; 2008 May; 141(5):615-21. PubMed ID: 18373706
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study.
    Kikuta A; Ohto H; Nemoto K; Mochizuki K; Sano H; Ito M; Suzuki H
    Vox Sang; 2006 Jul; 91(1):70-6. PubMed ID: 16756604
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur.
    Futani H; Minamizaki T; Nishimoto Y; Abe S; Yabe H; Ueda T
    J Bone Joint Surg Am; 2006 Mar; 88(3):595-603. PubMed ID: 16510827
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
    Tse W; Meshinchi S; Alonzo TA; Stirewalt DL; Gerbing RB; Woods WG; Appelbaum FR; Radich JP
    Blood; 2004 Nov; 104(10):3058-63. PubMed ID: 15217837
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.